ConductScience.org, home

Paper68814

Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.

Yagoda A. Cancer Res, 1977. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer. Papers, record 68814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/68814

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.68
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yagoda AA

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
CyclophosphamideMajor topic
DoxorubicinMajor topic
Urinary Bladder NeoplasmsMajor topic
Bleomycin
Clinical Trials as Topic
Drug Evaluation
Drug Synergism
Drug Therapy, Combination
Female
Humans
Male
Methotrexate
Neoplasm Metastasis

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
39564123Evaluating nivolumab plus gemcitabine-cisplatin's cost-effectiveness for aUC in China.Front Pharmacol2024https://conductscience.org/library/papers/39564123PubMed
7230204Cytotoxic chemotherapy in carcinoma of the bladder: a review.J R Soc Med1980https://conductscience.org/library/papers/7230204PubMed
6685581Phase-II trials in patients with urothelial tract tumors. Memorial Sloan-Kettering Cancer Center.Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6685581PubMed
6416699Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).Cancer Chemother Pharmacol1983https://conductscience.org/library/papers/6416699PubMed
6265016The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.Br J Pharmacol1981https://conductscience.org/library/papers/6265016PubMed
3835175Renal function, serum calcium and magnesium during treatment of advanced bladder carcinoma with cis-dichlorodiamineplatinum: impact of tumour site, patient age and magnesium suppletion.Int Urol Nephrol1985https://conductscience.org/library/papers/3835175PubMed
3311445
Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder.
Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3311445PubMed
2647312Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2647312PubMed
552498Treatment of infiltrating bladder cancer.J R Soc Med1979https://conductscience.org/library/papers/552498PubMed
389480Chemotherapy in the management of invasive bladder cancer. A review.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/389480PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/68814

GET https://conductscience.org/api/papers/v1/68814/authors